Originally posted by Nanoporous
View Post
Seqanswers Leaderboard Ad
Collapse
Announcement
Collapse
No announcement yet.
X
-
-
GenoMax/larissa
Be aware Illumina also made an $18 million investment in Oxford Nanopore when they entered a strategic alliance in January 2009.
Comment
-
ians - No lamda data yet, so far as I am aware, although the company did raise another $50m or so recently from existing shareholders. http://www.nanoporetech.com/news/press-releases/view/40
Comment
-
Hey all,
Interesting to read in the whole thread though I'm not really able to participate since I just recently joined the Seq community. So could anyone give me a short summary of what happened with the different platforms and how the market is developing at the moment? There has been so much going on that I lost track completely compared to what we were told during my studies (which was mainly focussing on the different techniques).
In short: who is still in business and which techniques survived so far?
Cheers
Comment
-
Originally posted by rboettcher View PostHey all,
Interesting to read in the whole thread though I'm not really able to participate since I just recently joined the Seq community. So could anyone give me a short summary of what happened with the different platforms and how the market is developing at the moment? There has been so much going on that I lost track completely compared to what we were told during my studies (which was mainly focussing on the different techniques).
In short: who is still in business and which techniques survived so far?
Cheers
Life: Could become market leader with their Proton sequencer in the near future.
Oxford Nanopore: Super cool technology but seriously lacks credibility. Remains to be seen whether they can live up to their promises.
The rest: Might be intesting in 5+ years or failed already.
Comment
-
454 used to be a viable option for certain appications, but nobody in their right mind would buy one of their sequencers today. Not with Illumina and Ion Torrent approaching 400 bp reads.
Helicos is pretty much dead.
PacBio is still alive and possibly intersting for niche appication but unlikely be able to survive on that.
Comment
-
Availability?
Does anyone have any info as to the date of commercial availability of the MinION?
Back in february they said 6-9 months, but not a peep since.
As a matter of fact, has anyone seen one of these in the wild? or anywhere for that matter?
Comment
-
Okay, this is anecdotal, but my wife was at an NIH awardees meeting in Washington a few months ago. This was for an education grant. One of the plenary speakers was Francis Collins. During his talk he held up a device about the size of a thumb drive and made some comments about the rapid progress of sequencing.
The weird thing was that he referred to this device as an Ion Torrent. But after the talk, as he was leaving the room, my wife asked him -- is than a MinIon? And he said that it was.
--
Phillip
Comment
-
Yeah, who knows if that was a live MinIon. Could have been, but it also could have been a mock-up given him by ONT. Or a random thumb drive. Also I wasn't there and this was a talk given to an audience not expert in sequencing tech. So he may just have been trying to make a point. Or meant something else...
--
Phillip
Comment
Latest Articles
Collapse
-
by seqadmin
During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.
Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...-
Channel: Articles
09-09-2024, 10:59 AM -
-
by seqadmin
The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...-
Channel: Articles
08-27-2024, 04:44 AM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, Today, 06:25 AM
|
0 responses
13 views
0 likes
|
Last Post
by seqadmin
Today, 06:25 AM
|
||
Started by seqadmin, Yesterday, 01:02 PM
|
0 responses
12 views
0 likes
|
Last Post
by seqadmin
Yesterday, 01:02 PM
|
||
Started by seqadmin, 09-18-2024, 06:39 AM
|
0 responses
14 views
0 likes
|
Last Post
by seqadmin
09-18-2024, 06:39 AM
|
||
Started by seqadmin, 09-11-2024, 02:44 PM
|
0 responses
14 views
0 likes
|
Last Post
by seqadmin
09-11-2024, 02:44 PM
|
Comment